［1］ Fox K A, Eagle K A, Gore J M, et al. The Global Registry of Acute Coronary Events, 1999 to 2009-GRACE ［J］. Heart，2010，96(14):1095-1101.
［2］ Wiiger M T， Prydz H. The changing faces of tissue factor biology. A personal tribute to the understanding of the “extrinsic coagulation activation” ［J］. Thromb Haemost，2007，98(1):38-42.
［3］ Carmeliet P, Mackman N, Moons L, et al. Role of tissue factor in embryonic blood vessel development ［J］. Nature，1996，383:73-75.
［4］ Cermak J, Key N S, Bach R R, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor ［J］. Blood，1993.82(2):513-520.
［5］ McGilvray I D, Tsai V, Marshall J C, et al. Monocyte adhesion and transmigration induce tissue factor expression: role of the mitogen-activated protein kinases ［J］. Shock，2012，18(1):51-57.
［6］ Cai H, Song C, Endoh I, et al. Serum amyloid A induces monocyte tissue factor ［J］. J Immunol，2007，178(3):1852-1860.
［7］ Braunersreuther V, Mach F，Steffens S. The specific role of chemokines in atherosclerosis ［J］. Thromb Haemost，2007，97(5):714-721.
［8］ Scholz H, Sandberg W, Damas J K, et al. Enhanced plasma levels of LIGHT in unstable angina: possible pathogenic role in foam cell formation and thrombosis ［J］. Circulation，2005，112(14):2121-2129.
［9］ Agraou B, Corseaux D, McFadden E P, et al. Effects of coronary angioplasty on monocyte tissue factor response in patients with stable or unstable angina ［J］. Thromb Res，1997，88(2):237-243.
［10］ Vieira L M, Dusse L M, Fernandes A P, et al. Monocytes and plasma tissue factor levels in normal individuals and patients with deep venous thrombosis of the lower limbs: potential diagnostic tools? ［J］. Thromb Res，2010，119(2):157-165.
［11］ Wolberg A S， Roubey R A. Mechanisms of autoantibody-induced monocyte tissue factor expression ［J］. Thromb Res，2004，114(5-6):391-396.
［12］ Lopez-Pedrera C, Buendia P, Barbarroja N, et al. Antiphospholipid-mediated thrombosis: interplay between anticardiolipin antibodies and vascular cells ［J］. Clin Appl Thromb Hemost，2006，12(1):41-45.
［13］ Kageyama K, Nakajima Y, Shibasaki M, et al. Increased platelet, leukocyte, and endothelial cell activity are associated with increased coagulability in patients after total knee arthroplasty ［J］. J Thromb Haemost，2011，5(4):738-745.
［14］ Keating F K, Dauerman H L, Whitaker D A, et al. Increased expression of platelet P-selectin and formation of platelet-leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide compared with bivalirudin ［J］. Thromb Res，2006，118(3):361-369.
［15］ Woollard K J, Suhartoyo A, Harris E E, et al. Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation ［J］. Circ Res，2008，103(10):1128-1138.
［16］ Poole J C. Phagocytosis of platelets by monocytes in organizing arterial thrombi. An electron microscopical study ［J］. Q J Exp Physiol Cogn Med Sci，1966，51(1):54-59.
［17］ Elstad M R, La Pine T R, Cowley F S, et al. P-selectin regulates platelet-activating factor synthesis and phagocytosis by monocytes ［J］. J Immunol，2009，155(4):2109-2122.
［18］ Simon D I, Ezratty A M, Francis S A, et al. Fibrin(ogen) is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): a nonplasmin fibrinolytic pathway ［J］. Blood，1993，82(8):2414-2422.
［19］ Kaplar M, Kappelmayer J, Veszpremi A, et al. The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy ［J］. Platelets，2001，12(7):419-422.
［20］ Furman M I, Benoit S E, Barnard M R, et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease ［J］. J Am Coll Cardiol，1998，31(2):352-358.
［21］ Furman M I, Barnard M R, Krueger L A, et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction ［J］. J Am Coll Cardiol，2001，38(4):1002-1006.
［22］ Tapp L D, Shantsila E, Wrigley B J, et al. The CD14^CD16⁺ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction ［J］. J Thromb Haemost，2012，10(7):1231-1241.
［23］ Zhao L, Bath P M, May J, et al. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPⅡb/Ⅲa antagonist ［J］. Platelets，2011，14(7-8):473-480.
［24］ Satta N, Freyssinet J M ，Toti F. The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide ［J］. Br J Haematol，1997，96(3):534-542.
［25］ Davies M J, Ballantine S J, Robertson W B, et al. The ultrastructure of organising experimental mural thrombi in the pig aorta ［J］. J Pathol，1975，117(2):75-81.
［26］ Wakefield T W, Linn M J, Henke P K, et al. Neovascularization during venous thrombosis organization: a preliminary study ［J］. J Vasc Surg，2009，30(5):885-892.
(2012-10-27